Sign out
Drug recalls
The United States Food and Drug Administration is responsible for protecting the public by assuring that medications sold in the United States are both safe and effective. Occasionally the FDA announces consumer-level recalls of medications for various reasons. Kaiser Permanente Pharmacy Operations responds to drug recall alerts initiated by the FDA and drug manufacturers by alerting our Members to recalls that may affect them. Members are alerted about recalls through the use of telephone messages and letters sent via the US Post Office. Below is a list of recently announced consumer-level drug recalls that may affect Kaiser Permanente Members.
Drug Name |
Recall Date |
Recall Documents |
Teligent Pharmaceuticals Lidocaine 4% (40 mg/mL) Topical Solution |
10/14/2021 |
|
Teligent Pharmaceuticals Lidocaine 4% (40 mg/ml) Topical Solution |
09/02/2021 |
|
Apotex Pharma Enoxaparin 100 mg, 120 mg Syringe Recall |
02/03/2021 |
|
Epinephrine Injector 0.3 mg (Adrenaclick) |
06/24/2020 |
|
Metformin Extended Release Tablets |
06/15/2020 |
|
Acella Pharmaceuticals NP Thyroid 30 mg, 60 mg, and 90 mg Tablets |
06/04/2020 |
|
Heritage Pharmaceuticals Tetracycline 250 mg and 500 mg capsules |
04/30/2020 |
|
All Manufacturers of Ranitidine Products |
04/13/2020 |
|
Taro Pharmaceuticals Lamotrigine 100 mg Tablets |
02/25/2020 |
|
Taro Pharmaceuticals Phenytoin 125 mg/5 mL Suspension |
02/25/2020 |
|
Aurobindo Pharmaceuticals Mirtazapine 7.5 mg, 15 mg Tablets |
01/07/2020 |
|
Lannett Pharmaceuticals Levetiracetam 100 mg/mL Oral Solution Recall |
12/24/2019 |